Search

Learn how rectal cancer patients with HER2 driven tumors benefited from an early stage clinical trial at MSK.

… Saturday, April 18, 2026 A clinical trial at Memorial Sloan Kettering Cancer Center (MSK) is showing promise for people with early-stage rectal cancer whose tumors are driven by excessive amounts of a protein called HER2 (human epidermal growth factor receptor 2). The trial suggests that many of these

Dozens of clinicians and scientists from across MSK presented the latest advances in cancer research at the 2026 American Association for Cancer Research (AACR) Annual Meeting, held April 17 to 22 in San Diego.

… Wednesday, April 22, 2026 Dozens of clinicians and scientists from across Memorial Sloan Kettering Cancer Center (MSK) presented the latest advances in cancer research at the 2026 American Association for Cancer Research (AACR) Annual Meeting , held April 17 to 22 in San Diego.  MSK’s presence spanned

Whether you’ve been diagnosed with a rare cancer or one that’s more common, MSK doctors can provide a second opinion.

… Thursday, December 18, 2025 Learning that you have cancer can be an overwhelming experience. As you begin researching what steps to take after receiving a  cancer diagnosis , you’ll probably hear a lot about getting a second opinion. Memorial Sloan Kettering Cancer Center (MSK) provides second opinions

Ya sea que le hayan diagnosticado un tipo de cáncer poco común u otro más común, los médicos de MSK pueden brindarle una segunda opinión.

… Thursday, December 18, 2025 Enterarse de que tiene cáncer puede ser una experiencia abrumadora. Al comenzar a investigar cómo proceder luego de recibir un  diagnóstico de cáncer , probablemente escuche hablar mucho de una segunda opinión. Memorial Sloan Kettering Cancer Center (MSK) da segundas opiniones

Drs. Anna-Katerina Hadjantonakis and Robert Farese were elected to the 2026 class of the American Academy of Arts and Sciences.

… Thursday, April 23, 2026 Two Memorial Sloan Kettering Cancer Center (MSK) researchers were elected to the 2026 class of the American Academy of Arts and Sciences. Developmental biologist Anna-Katerina Hadjantonakis, PhD , and physician-scientist Robert Farese, Jr., MD , were among the 252 leaders in

In this Q&A series, we speak with former MSK trainees as they reflect on their career paths, share insights from their current work, and discuss how their experiences at MSK continue to inform the way they practice, lead and innovate. These conversations bring to life the lasting impact of training at MSK, and the evolving ways our alumni shape clinical practice, and advance care for patients.

… Friday, April 24, 2026 Memorial Sloan Kettering Cancer Center’s (MSK)  graduate medical education programs train the next generation of physician leaders in oncology - fostering innovation that drives meaningful clinical and scientific advances. In this Q&A series, we speak with former MSK trainees as

Learn about dense breast tissue and what it means for your cancer risk and screening needs.

… Tuesday, May 27, 2025 Having dense breasts is a  risk factor for breast cancer . But how do you know if you have dense breasts, and how should it affect the way you approach screening for the disease? Radiologist Elise Desperito, MD , Director of Breast Imaging at the  MSK Ralph Lauren Center , shares

Nearly two thirds of patients who were treated with the combination enfortumab vedotin plus pembrolizumab saw their tumors shrink.

… Monday, September 12, 2022 Researchers from Memorial Sloan Kettering Cancer Center (MSK) shared a promising treatment option for bladder cancer patients today at The European Society for Medical Oncology (ESMO) Congress 2022. Jonathan E. Rosenberg, MD , medical oncologist and Chief of the Genitourinary

Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer discovery during the American Association for Cancer Research (AACR) Annual Meeting on April 5-10 in San Diego, California.

… Monday, April 1, 2024 Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer discovery during the American Association for Cancer Research (AACR) Annual Meeting

Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer during the American Association for Cancer Research (AACR) Annual Meeting on April 14-19 in Orlando, Florida.

… Wednesday, April 12, 2023 Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer during the American Association for Cancer Research (AACR) Annual Meeting on April